Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Legit62on Mar 02, 2022 6:26pm
227 Views
Post# 34477080

RE:RE:New Australian Study Discusses TLD1433

RE:RE:New Australian Study Discusses TLD1433Great article, i was wondering about phase III ? My thoughts on releasing trial data later than we all expected was probably due to covid,possibly delaying results a bit,and feeling they want to release best results at best time, even if it makes all of us go a little crazy, rather get great results when all said and done, might come before newsletter and quarterlies, or with newsletter. We all know the science is there, its just a matter of time and i think all our posts guessing time frame for release spooked some new investors who might have just picked up shares, im holding long and tight, cause i feel when the results come in, we will all be happy. To reiterate we have Dr Vera now, very, very positive addition to tlt and our moving foward IMO
<< Previous
Bullboard Posts
Next >>